Fred Alger Management, LLC Renalytix PLC Transaction History

Fred Alger Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.19 - $2.78 $72 - $169	61 Added 0.02%	307,642 $394,000
Q2 2022 Aug 15, 2022	SELL	$2.45 - $7.81 $15,033 - $47,922	-6,136 Reduced 1.96%	307,581 $754,000
Q1 2022 May 16, 2022	SELL	$5.88 - $15.9 $10,501 - $28,397	-1,786 Reduced 0.57%	313,717 $2.17 Million
Q4 2021 Feb 14, 2022	SELL	$13.43 - $27.4 $1.36 Million - $2.78 Million	-101,588 Reduced 24.36%	315,503 $5.02 Million
Q3 2021 Nov 15, 2021	SELL	$17.91 - $34.78 $1.95 Million - $3.79 Million	-108,893 Reduced 20.7%	417,091 $8.36 Million
Q2 2021 Aug 16, 2021	BUY	$23.56 - $34.25 $4.43 Million - $6.44 Million	188,017 Added 55.63%	525,984 $16.2 Million
Q1 2021 May 17, 2021	BUY	$15.25 - $31.13 $5.15 Million - $10.5 Million	337,967 New	337,967 $8.67 Million

3.91M

13.7K

Ticker RNLX
Exchange OTC
Sector Healthcare
Industry Health Information Services
Shares Outstandng 37,445,900
Market Cap $5.62M
Description
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.